On April 25, 2024, the company announced that it has extended its plan duration till February 5, 2025.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.74 CNY | -1.19% |
|
+1.03% | -23.29% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.29% | 1.26B | |
+56.09% | 816B | |
+39.36% | 634B | |
-7.55% | 351B | |
+16.30% | 323B | |
+7.32% | 293B | |
+13.13% | 238B | |
+0.78% | 222B | |
+13.22% | 218B | |
+8.11% | 167B |
- Stock Market
- Equities
- 600557 Stock
- News Jiangsu Kanion Pharmaceutical Co.,Ltd.
- Jiangsu Kanion Pharmaceutical Co.,Ltd. Equity Buyback Plan Extended till February 5, 2025.